Seventh - I disagree. As I had mentioned before, I read the initial descriptions provided for the CNS Summit on 9/11, and the original language regarding MS ( which was pulled after about 20 minutes ) emphatically stated that 2-73 induces remyelination, not " May " or " has the potential to "; it was as affirmative a statement as " restores homeostasis ". I remember this vividly and remember thinking at the time, " Wow ".
I think the parties ( BIIB and AVXL ) have been significantly a part on the economics, hence AVXL presenting MS data at the CNS Summit, which was a shot across the bow to BIIB, exposing it to potential MS competitors.
My crystal ball says we have a MS partnership with BIIB announced before the end of the year.
News 
Market Data 
Discover 
